Skip to main content
APLS logo

APLS · Apellis Pharmaceuticals, Inc.

Track APLS — free
Market Cap
$5.25B
Shares
128.02M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-08-31 Scheduled
FINRA publishes Sep 10
2026-08-14 Scheduled
FINRA publishes Aug 25
2026-04-30 10,752,810 14,239,228 -3,486,418 3.06
2026-04-15 14,239,228 25,123,090 -10,883,862 1.75
2026-03-31 25,123,090 22,929,613 +2,193,477 2.64
2026-03-13 22,929,613 22,934,760 -5,147 11.91
2026-02-27 22,934,760 24,683,240 -1,748,480 12.12
2026-02-13 24,683,240 21,239,349 +3,443,891 11.26
2026-01-30 21,239,349 18,109,597 +3,129,752 4.76
2026-01-15 18,109,597 16,120,529 +1,989,068 5.26
2025-12-31 16,120,529 17,247,829 -1,127,300 7.29
2025-12-15 17,247,829 16,097,117 +1,150,712 7.71
2025-11-28 16,097,117 16,349,387 -252,270 7.55
2025-11-14 16,349,387 15,213,060 +1,136,327 5.59
2025-10-31 15,213,060 18,061,349 -2,848,289 4.43
2025-10-15 18,061,349 21,047,108 -2,985,759 8.09
2025-09-30 21,047,108 21,758,081 -710,973 9.31
2025-09-15 21,758,081 20,539,985 +1,218,096 9.67
2025-08-29 20,539,985 20,273,707 +266,278 11.61
Showing 1–17 of 17 settlements
Key facts CIK 1492422 CUSIP 03753U106 13F (30d) 8 filings 5 filers Visit website